TRIB
Trinity Biotech
TRIB
TRIB
26 hedge funds and large institutions have $22.6M invested in Trinity Biotech in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.09% less ownership
Funds ownership: 1.51% → 1.42% (-0.09%)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
26
Holding in Top 10
–
Calls
$460K
Puts
$145K
Top Buyers
| 1 | +$878K | |
| 2 | +$489K | |
| 3 | +$417K | |
| 4 |
Millennium Management
New York
|
+$306K |
| 5 |
NA
Navellier & Associates
Reno,
Nevada
|
+$248K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$995K | |
| 3 | -$133K | |
| 4 |
Morgan Stanley
New York
|
-$124K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$105K |